Arena ADVISE - Home

Stop hidingfrom your moderate-to-severe eczema

The ADVISE Study is evaluating the safety and effectiveness of an investigational drug, taken orally, designed for moderate-to-severe eczema.

Let’s work together to find a potential new treatment for this frustrating condition.

You may be able to take part in the ADVISE Study if:

You will receive all study-related care at no cost.

About Eczema

Eczema is a term used to describe medical conditions that cause red, inflamed, and itchy skin.

Over

0 Million

Australians have eczema

Eczema is more common in females than males

The most common form of eczema, atopic dermatitis, is caused by a dysregulated immune system

Eczema will affect one in three Australians at some point in their lives

In order to improve the quality of life in those with moderate-to-severe eczema, more research is needed.

Sources: nationaleczema.org
eczema.org.au
allergyfacts.org.au
Chiesa Fuxench ZC, et al. Atopic Dermatitis in America Study: A Cross-Sectional Study Examining the Prevalence and Disease Burden of Atopic Dermatitis in the US Adult Population. J Invest Dermatol. 2019 Mar;139(3):583-590

If moderate-to-severe eczema is something you struggle with, consider joining the ADVISE Study now

Your choice regarding cookies on this site

We use cookies to optimize site functionality and give you the best experience. Necessary cookies enable core functionality. The website cannot function properly without these cookies, and can only be disabled by changing your browser preferences.

For more detailed information on the cookies we use, please check our Privacy Policy.

By continuing to access this website you are giving us consent to collect cookies.